Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Hematology/Oncology and Stem Cell Therapy|March 11, 2017
CXCR4 (CD184) expression on stem cell harvest and CD34<sup>+</sup> cells post-transplantInas Asfour, Hanaa Afify, Shaza Elkourashy, et al.
Cancer Biomarkers : Section a of Disease Markers|March 29, 2021
Overexpression of BAMBI and SMAD7 impacts prognosis of acute myeloid leukemia patients: A potential TERT non-canonical roleMiral Magdy Shehata, Al-Aliaa Mohamed Sallam, Mary Gamal Naguib, et al.
Global Journal on Quality and Safety in Healthcare|November 13, 2024
National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in EgyptMary Gamal, Amal Samir Sedrak, Gihan Hamdy Elsisi, et al.
Frontiers in Pharmacology|November 28, 2022
Institutionalizing health technology assessment in Egypt: Situational analysis and roadmapPilar Pinilla-Dominguez, Shorouk Taha, Hugh McGuire, et al.
Transplant Immunology|April 9, 2026
Poor graft function after allogeneic hematopoietic stem cell transplantation is associated with a severely altered bone marrow endothelial microenvironment, as revealed by CD31 expression: An Egyptian single center experienceMary Gamal Naguib, Nermin Adel Nabih Abdel-Ghafar, Soha Raouf Youssef Mikhaeil, et al.
Value in Health Regional Issues|May 4, 2024
Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa RegionBaher Elezbawy, Mohamed Farghaly, Atlal Al Lafi, et al.
International Journal for Equity in Health|February 26, 2025
Rare disease challenges and potential actions in the Middle EastAhmad Nader Fasseeh, Nada Korra, Ahmed Aljedai, et al.
Journal of Pharmaceutical Policy and Practice|March 2, 2022
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in EgyptBaher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, et al.
The Journal of the Egyptian Public Health Association|June 2, 2024
Framework for developing cost-effectiveness analysis threshold: the case of EgyptAhmad N Fasseeh, Nada Korra, Baher Elezbawy, et al.
BMC Medical Informatics and Decision Making|November 10, 2022
A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in EgyptBaher Elezbawy, Ahmad Nader Fasseeh, Bertalan Németh, et al.
Pageof 2